logo

The COVID-NMA initiative
A living mapping and living systematic review of Covid-19 trials

COVID-NMA is an international research initiative supported by the WHO and Cochrane.

We provide a living mapping of COVID-19 trials. We are also conducting living evidence synthesis on preventive interventions, treatments and vaccines for COVID-19 to assist decision makers.

See the description of our model here and our living review protocol here.

LIVING MAPPING OF TRIALS

(i.e., trials registered on the WHO platform)
Updated weekly

3090
Randomized Trials
1535 RCTs recruiting

2501
RCTs on treatments
(1284 recruiting)

330
RCTs on prevention
(139 recruiting)

259
RCTs on vaccines
(112 recruiting)

LIVING SYNTHESIS OF PUBLISHED TRIALS

(include both articles and preprints)
Updated daily

330
RCTs with complete data extraction and results
included in our evidence synthesis

271
RCTs on treatments

16
RCTs on prevention

43
RCTs on vaccines

Weekly update

June 7 to June 11, 2021: see the update here.

Newsletter

To receive updates on our project, please subscribe below.

This work received some funding from the Agence Nationale de la Recherche (ANR), the World Health Organization (WHO), Cochrane France, Center of Research in Epidemiology and StatisticS (CRESS), Centre d’Epidémiologie Clinique (GHU Cochin, Hôtel Dieu, Assistance Publique Hôpitaux de Paris (APHP) and Université de Paris), Centre national de la recherche scientifique (CNRS) and the Federal Ministry of Health, Germany